Chronic Stroke Patients
Conditions
Keywords
Chronic Stroke Patients, Balance, Plantar Pressure Distribution, Respiratory Parameters, Backward Gait Training
Brief summary
Loss of motor control after stroke, muscle weakness, abnormal movement patterns, spasticity, range of motion limitations and sensory dysfunction, resulting in a decrease in the load transferred to the affected limb, changes in gait pattern and balance skills. Post-stroke muscle weakness has been shown to occur not only in the lower and upper extremity muscles but also in the respiratory muscles. It was found that the plantar pressure distribution in the affected side feet was decreased in individuals with stroke and this situation negatively affected the walking function. A systematic review of treadmill training revealed that treadmill training significantly increased walking speed and walking distance. Learning to walk backwards is also recommended to improve the movement components required for walking forward. As a result of the investigations, although there are studies about the effects of back-walking training on walking and balance function in chronic stroke patients, there is no study investigating the effects on plantar pressure distribution and respiratory parameters. Therefore, this study, which planned to investigate the effects of treadmill retching training on balance, plantar pressure distribution and respiratory parameters in chronic stroke patients, will contribute to the literature.
Interventions
The training speed will start at the basic walking speed and will increase by 5% of the starting speed each week. The training, which will take 30 minutes, will be as follows: 5 minutes forward walking (warm-up phase), 20 minutes backward walking (intervention phase) and 5 minutes forward (cooling phase). -three times a week for six weeks
The training speed will start at the basic walking speed and will increase by 5% of the starting speed each week. It will be in the form of walking forward for 30 minutes. -three times a week for six weeks
Sponsors
Bandırma Onyedi Eylül University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Volunteering to participate in the study * More than 6 months have passed since the onset of stroke * First time stroke diagnosis * Being between the ages of 40-65 * Spasticity severity in lower extremity less than 3 according to Modified Ashworth Scale, * Being medically stable * Ability to walk 10 meters and above without assistance
Exclusion criteria
* Presence of other neurological or orthopedic diseases that affect standing and walking involving the lower limbs * Uncontrollable Hypertension * Having been diagnosed with any pulmonary disease * Severe cardiac conditions * Uncontrollable DM * Lack of cooperation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Plantar pressure assessment | 6 weeks | Plantar pressure distribution will be evaluated. |
| Balance assessment | 6 weeks | Static and dynamic balance will be evaluated with The Korebalance Premiere device. |
| Pulmonary function (Forced vital capacity (FVC)) | 6 weeks | Pulmonary function will be evaluated with the spirometry. Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria. With the device, forced vital capacity (FVC) will be evaluated. |
| Pulmonary function (Forced expiratory volume in the first second (FEV1)) | 6 weeks | Pulmonary function will be evaluated with the spirometry. Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria. With the device, forced expiratory volume in the first second (FEV1) will be evaluated. |
| Pulmonary function (FEV1 / FVC) | 6 weeks | Pulmonary function will be evaluated with the spirometry. Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria. With the device, FEV1 / FVC will be evaluated. |
| Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) | 6 weeks | Pulmonary function will be evaluated with the spirometry. Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria. With the device, flow rate 25-75% of forced expiratory volume (FEF 25-75%) will be evaluated. |
| Pulmonary function (Peak flow rate (PEF)) | 6 weeks | Pulmonary function will be evaluated with the spirometry. Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria. With the device, peak flow rate (PEF) will be evaluated. |
| Respiratory Muscle Strength | 6 weeks | Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) will be measured using portable, electronic, oral pressure measuring device |
Countries
Turkey (Türkiye)
Contacts
Primary ContactBurçin Akçay
Outcome results
None listed